Antony Chadderton

Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors

Jesús R. Medina, Christopher Becker, Charles W. Blackledge et al. · Journal of Medicinal Chemistry · 2011 · 53 citations · Full text

Drug Target, Chemoprevention Strategy, Chemical Biology +20

Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells

Antony Chadderton, David J. Villeneuve, Stefan Glück et al. · Breast Cancer Research and Treatment · 2000 · 41 citations

Breast Oncology, Paclitaxel-induced Apoptosis, Medicine +9

Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag

Connie L. Erickson‐Miller, Jennifer Kirchner, Manuel Aivado et al. · Leukemia Research · 2010 · 40 citations

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +12

Selection of normalizer genes in conducting relative gene expression analysis of embryos

Qin J. Zhang, Antony Chadderton, Robert L. Clark et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2003 · 22 citations · Full text

Lack of modulation ofMDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant mcf-7 breast cancer cells

Amadeo M. Parissenti, Brian R. Gannon, David J. Villeneuve et al. · International Journal of Cancer · 1999 · 18 citations